Jerod Funke - 12 May 2026 Form 4 Insider Report for InfuSystem Holdings, Inc (INFU)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
14 May 2026, 18:28:57 UTC
Prior SEC filing
14 Oct 2025
Next SEC filing
19 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Kevin Whitman, Attorney-in-Fact for Jerod Funke

Key filing fact

Jerod Funke filed Form 4 for InfuSystem Holdings, Inc (INFU) on 14 May 2026.

Key facts

  • This page summarizes Jerod Funke's Form 4 filing for InfuSystem Holdings, Inc (INFU).
  • 2 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 14 May 2026, 18:28.

Change

  • Previous filing in this sequence was filed on 14 Oct 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001998115 Primary reporting owner

Funke Jerod

Relationship
EVP-Chief HR Officer
Address
C/O INFUSYSTEM HOLDINGS, INC., 3851 WEST HAMLIN ROAD, ROCHESTER HILLS
Signature
/s/ Kevin Whitman, Attorney-in-Fact for Jerod Funke
Signature date
14 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INFU holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
18,662
Date
12 May 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

INFU transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares
+23,913
Change %
Price
$0.000000*
Shares after
23,913
Date
12 May 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
23,913
Exercise price
$8.37
Footnotes
F1
INFU transaction Derivative

Restricted Stock Units

Award

Transaction value
Shares
+11,478
Change %
Price
$0.000000*
Shares after
11,478
Date
12 May 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
11,478
Exercise price
Footnotes
F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The option, representing the right to purchase a total of 23,913 shares of InfuSystem Holdings, Inc. common stock, vests in four equal annual installments beginning May 12, 2027.

Footnote F2

Restricted stock units convert into common stock on a one-for-one basis.

Footnote F3

These restricted stock units vest in three equal annual installments beginning on May 12, 2027.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .